Microwave Ablation for Pancreatic and Liver Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.
Who Is on the Research Team?
Neil Sharma, MD
Principal Investigator
Banner Health (Banner MD Anderson Cancer Center at Gateway Medical Center)
Are You a Good Fit for This Trial?
This trial is for adults with pancreatic, liver, or biliary tract cancer that cannot be removed by surgery or has spread. Participants should have locally advanced or metastatic disease and be able to undergo an endoscopic procedure.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- EUS-Guided Microwave Ablation Device
Trial Overview
The study tests a new treatment using an ultrasound-guided microwave ablation (MWA) device to target tumors in the pancreas, liver, or bile ducts. The main goal is to see if the device can safely deliver energy and shrink tumors.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This is a open label feasibility study and only eligible participants will be enrolled into the single arm of the study to receive MWA with this specific device.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Banner Health
Lead Sponsor
Creo Medical Limited
Industry Sponsor
CreoMed, Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.